Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
NCT02099981Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of aminoguanidine in diabetic retinopathy (DR) (2 arms), sponsored by University of Minnesota. Primary endpoint: The vascular response to flicker at 90 minutes. Started Jul 2016; status: completed.
02
Drugs
aminoguanidine
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT02099981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099981.